ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Xeris Biopharma Holdings Inc

Xeris Biopharma Holdings Inc (XERS)

4,24
0,11
(2,66%)
Fermé 10 Mars 9:00PM
4,25
0,01
(0,24%)
Après les heures de négociation: 1:59AM

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
4,25
Prix Achat
3,48
Prix Vente
4,55
Volume échangé
6 001 110
4,05 Fourchette du Jour 4,40
1,69 Plage de 52 semaines 4,50
Cap du marché
Clôture Veille
4,13
Ouverture
4,12
Dernière Transaction
70
@
4.24
Dernière heure de transaction
Volume financier
US$ 25 457 561
VWAP
4,2421
Volume moyen (3 m)
1 713 997
Actions en circulation
149 081 461
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-10,13
Bénéfice par action (BPA)
-0,42
Chiffre d'affairess
163,91M
Bénéfice net
-62,26M

À propos de Xeris Biopharma Holdings Inc

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company markets Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalem... Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company markets Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago, Illinois. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Wilmington, Delaware, USA
Fondé
-
Xeris Biopharma Holdings Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker XERS. Le dernier cours de clôture d'Xeris Biopharma était de US$4,13. Au cours de la dernière année, les actions de Xeris Biopharma ont été négociées dans une fourchette de prix de US$ 1,69 à US$ 4,50.

Xeris Biopharma compte actuellement 149 081 461 actions en circulation. La capitalisation boursière d'Xeris Biopharma est de US$615,71 million. Xeris Biopharma a un ratio cours/bénéfice (ratio PE) de -10.13.

XERS Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.513.33333333333.754.53.5930813953.98338272CS
40.6317.40331491713.624.53.44522102253.84448459CS
120.8625.36873156343.394.53.1417139973.6221005CS
261.7469.32270916332.514.52.5116518313.36412766CS
521.7267.98418972332.534.51.6915666342.81777468CS
1561.9685.58951965072.294.50.970114031452.36022385CS
2601.8980.08474576272.367.940.970118772683.07581064CS

XERS - Frequently Asked Questions (FAQ)

What is the current Xeris Biopharma share price?
The current share price of Xeris Biopharma is US$ 4,25
How many Xeris Biopharma shares are in issue?
Xeris Biopharma has 149 081 461 shares in issue
What is the market cap of Xeris Biopharma?
The market capitalisation of Xeris Biopharma is USD 615,71M
What is the 1 year trading range for Xeris Biopharma share price?
Xeris Biopharma has traded in the range of US$ 1,69 to US$ 4,50 during the past year
What is the PE ratio of Xeris Biopharma?
The price to earnings ratio of Xeris Biopharma is -10,13
What is the cash to sales ratio of Xeris Biopharma?
The cash to sales ratio of Xeris Biopharma is 3,85
What is the reporting currency for Xeris Biopharma?
Xeris Biopharma reports financial results in USD
What is the latest annual turnover for Xeris Biopharma?
The latest annual turnover of Xeris Biopharma is USD 163,91M
What is the latest annual profit for Xeris Biopharma?
The latest annual profit of Xeris Biopharma is USD -62,26M
What is the registered address of Xeris Biopharma?
The registered address for Xeris Biopharma is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Xeris Biopharma website address?
The website address for Xeris Biopharma is www.xerispharma.com
Which industry sector does Xeris Biopharma operate in?
Xeris Biopharma operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
CAPSCapstone Holding Corp
US$ 3,50
(1 300,00%)
36,33k
ABLVAble View Global Inc
US$ 1,73
(137,18%)
5,13M
SUNESUNation Energy Inc
US$ 0,402999
(127,55%)
476,73M
BTOGBit Origin Ltd
US$ 0,6117
(118,46%)
618,03M
DWTXDogwood Therapeutics Inc
US$ 6,63
(49,66%)
25,77M
ALBTAvalon GloboCare Corporation
US$ 6,96
(-36,15%)
577,55k
SCNXScienture Holdings Inc
US$ 1,55
(-35,68%)
1,59M
ACXPAcurx Pharmaceuticals Inc
US$ 0,4572
(-29,88%)
1,18M
RETOReTo Eco Solutions Inc
US$ 5,42
(-27,73%)
108,27k
OCTOEightco Holdings Inc
US$ 1,08
(-27,03%)
336,99k
BTOGBit Origin Ltd
US$ 0,6117
(118,46%)
622,67M
SUNESUNation Energy Inc
US$ 0,402999
(127,55%)
482,05M
NVDANVIDIA Corporation
US$ 112,69
(1,92%)
341,94M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10,675
(-0,70%)
143,04M
ICONIcon Energy Corporation
US$ 0,169898
(17,17%)
142,23M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock